A vascular practice and its physician, Dr. Feliciano Serrano, have agreed to pay more than $6.73 million to resolve allegations that they violated the False Claims Act by submitting false claims for medically unnecessary vascular interventional procedures performed on 20 Medicare beneficiaries.DOCUMENTED
Under the terms of the settlement, Dr. Serrano will pay nearly $6.51 million to the United States and nearly $229,000 to the State of California.DOCUMENTED
- Dr. Feliciano Serrano and his practice agreed to pay more than $6.73 million combined.
- The settlement resolves allegations tied to medically unnecessary vascular interventional procedures on 20 Medicare beneficiaries.
- The case was brought under the False Claims Act's qui tam whistleblower provisions.
- Relator Lincoln Analytics Inc. will receive approximately $976,000 as its share of the federal recovery.
- The case was filed in the U.S. District Court for the Central District of California.
What "medically unnecessary" means in this context
Vascular interventional procedures — treatments addressing blocked or narrowed blood vessels, often performed using catheters and imaging guidance rather than open surgery — are billable to Medicare only when a patient's documented condition actually meets the clinical criteria establishing that the procedure is medically necessary.REVIEWED The complaint alleges that for 20 identified Medicare beneficiaries, Dr. Serrano performed and billed for these procedures without that underlying medical necessity being present, meaning Medicare paid for interventions that the patients' actual clinical presentations did not justify.DOCUMENTED
Because vascular interventional procedures carry real physical risk in addition to their cost, allegations of unnecessary use raise a concern beyond the financial harm to federal health programs: patients may have been exposed to procedural risk without a corresponding medical benefit.REVIEWED
The whistleblower behind the case
The lawsuit was brought under the qui tam provisions of the False Claims Act by relator Lincoln Analytics Inc., captioned United States and State of California ex rel. Lincoln Analytics Inc. v. Dr. Feliciano Serrano, et al.DOCUMENTED Lincoln Analytics will receive approximately $976,000 as its share of the federal recovery, consistent with the law's structure for compensating private parties who bring forward evidence of fraud against government health programs.DOCUMENTED
The procedures at issue carry genuine medical risk in addition to their billing value — meaning allegations of unnecessary use raise a patient-safety concern layered on top of the financial harm to Medicare.
How this kind of case typically comes to light
Cases alleging medically unnecessary procedures generally originate from someone with direct visibility into a practice's clinical decision-making or billing patterns — a role a data-analytics relator like Lincoln Analytics can fill by reviewing Medicare billing data for patterns inconsistent with typical clinical practice, such as an unusually high rate of a specific procedure relative to a physician's patient population or peer benchmarks.REVIEWED That kind of statistical pattern analysis has become an increasingly common entry point for False Claims Act whistleblower cases in health care, supplementing the more traditional model of an insider employee reporting misconduct they witnessed directly.REVIEWED
Part of continued government scrutiny of interventional procedures
The resolution was the product of a coordinated effort between the Justice Department's Civil Division, Commercial Litigation Branch, Fraud Section, and other federal partners, reflecting sustained attention to medical necessity standards across procedure-based specialties where reimbursement rates for a single intervention can be substantial.REVIEWED As with other False Claims Act settlements, the claims resolved here are allegations only, and there has been no court determination of liability against Dr. Serrano or his practice.REVIEWED
Why procedure-based medicine draws particular scrutiny
Interventional specialties that bill per-procedure, rather than per-visit or per-diagnosis, create a financial structure where a physician's own volume of procedures directly drives revenue in a way that primary care or purely diagnostic specialties typically do not.REVIEWED That structure has made vascular intervention, alongside similar procedure-heavy fields like cardiac catheterization and certain orthopedic surgeries, a recurring focus of Medicare fraud enforcement, since the same statistical tools that flag an unusually high billing rate can apply across any specialty where a single physician's practice pattern can be measured against a broader peer benchmark.REVIEWED
Patients who have undergone a vascular intervention and have questions about whether the procedure was medically indicated can request their complete medical records and, if concerned, seek an independent second opinion from a physician unaffiliated with the practice that performed the original procedure.REVIEWED
The roughly $6.51 million paid to the federal government, against the nearly $229,000 paid to California, reflects the proportional split typical of cases where Medicare, a federal program, bore the overwhelming majority of the alleged financial harm, with a smaller state Medicaid share layered on top. That division reflects how many health care fraud settlements ultimately involve more than one government payer, even when the bulk of the allegedly false billing flowed through the federal Medicare program specifically.REVIEWED
What the settlement does and doesn't establish
Because the matter was resolved through a civil settlement rather than a trial, the resolution does not include any criminal charges against Dr. Serrano, and the specific clinical details of why each of the 20 procedures was found lacking in medical necessity have not been made public in the same way a full trial record might disclose them.REVIEWED Settlements of this kind typically remain confidential as to the underlying clinical review methodology, even as the topline allegations and dollar figures become public through the Justice Department's own announcement.REVIEWED
For Medicare beneficiaries generally, the case reinforces a point relevant well beyond vascular medicine specifically: a recommended procedure, however routine it may sound, is worth understanding in plain terms before consenting to it, including asking directly what specific finding or symptom makes the procedure necessary in your case rather than simply accepting a scheduling recommendation. That question costs nothing to ask and can prompt a clearer conversation about the actual medical basis for any recommended intervention, and it applies just as usefully to a routine referral as it does to a more invasive surgical procedure, regardless of which particular medical specialty happens to be involved.REVIEWED
Sources behind this report
Have documents relevant to this story? Reach us through our tips channel.